4-Carboxyisothiazole NEW
Price | $30 |
Package | 50mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-19 |
Product Details
Product Name: 4-Carboxyisothiazole | CAS No.: 822-82-2 |
Purity: 99.64% | Supply Ability: 10g |
Release date: 2024/11/19 |
Product Introduction
Bioactivity
Name | 4-Carboxyisothiazole |
Description | 4-Carboxyisothiazole is a useful organic compound for research related to life sciences. The catalog number is T4675 and the CAS number is 822-82-2. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 50 mg/mL (387.18 mM) |
Keywords | 4-Carboxyisothiazole | 4 Carboxyisothiazole | 4Carboxyisothiazole |
Related Compound Libraries | Bioactive Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$180.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-06-05 | |
$79.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-16 | |
$0.00/1KG |
VIP5Y
|
Zhejiang Free Trade Zone Violet Trade Co., Ltd.
|
2020-11-20 | |
$6.60/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-02 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hills
INQUIRY